You are here:
Publication details
Genetic polymorphisms associated with risk of venous thromboembolism in multiple myeloma patients treated with thalidomide.
Authors | |
---|---|
Year of publication | 2011 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Description | Venous thromboembolism (VTE) is a common side-effect of thalidomide treatment in patients with multiple myeloma (MM). In our retrospective study, we analyzed candidate single-nucleotide polymorphisms (SNPs) - CINP (rs7011), CETP (rs289747), ALDH1A1 (rs610529), CDKN1A (rs3829963), GAN (rs2608555), VEGF (rs699947) and ALDH1A1 (rs168351). Further studies are needed to confirm the initial analysis that provided predictive information of genetic variations in myeloma patients that may influence risk of VTE. |
Related projects: |